Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/189351
Title: | HIV-positive women have higher prevalence of comorbidites and anticholinergic burden. Assessment of the HIV positive population from Menorca (Balearic Islands) |
Author: | Mercadal-Orfila, Gabriel Font, Julia Pons, Marta Blasco Mascaró, Ignacio Piqué i Clusella, Núria |
Keywords: | Infeccions per VIH VIH (Virus) Dones HIV infections HIV (Viruses) Women |
Issue Date: | 2022 |
Publisher: | Taylor and Francis |
Abstract: | Currently, the management of comorbidities and polypharmacy in HIV-infected patients requires a coordinated action, with special focus on gender differences. Observational, cross-sectional study was conducted to study the HIV population from Menorca (Illes Balears). Adult HIV-positive individuals on antiretroviral treatment attending the pharmacy service from Hospital Mateu Orfila (Menorca) were included. In a single visit, demographical and clinical characteristics, comorbidities and cotreatments were collected. Anticholinergic burden (Drug Burden Index, DBI), drug-to-drug interactions (BOT PLUS database) and symptoms associated with HIV treatment (HIV-SI index) were assessed. A total of 223 patients were included, 68.2% men, with a median age of 53.00 (44.50-58.00) years, median BMI of 24.07, 47.73% smokers and 9.90% drug consumers. Women had more advanced stages of the disease and significantly more symptoms (cough and anxiety) versus men (p = .033 and p = .048, respectively). Moreover higher exposures to anticholinergic drugs (DBI 0.51 vs. 0.27) were reported, together with more frequency of drug-to-drug interactions (57.7% vs. 37.5%; p = .005) that increased with age. Red interactions were more frequently reported in PI (2.69%), NNRTIs (1.92%) and booster drugs (1.92%). These results support the need to implement specific measures for the management of HIV-infected women and tools to assess polypharmacy and risk of drug-to-drug interactions. Keywords: HIV infection; anticholinergic burden; anxiety; comorbidities; drug-to-drug interactions; women. |
Note: | Reproducció del document publicat a: https://doi.org/10.1080/09540121.2022.2067518 |
It is part of: | Aids Care-Psychological and Socio-Medical Aspects of Aids/Hiv, 2022, p. 1-10 |
URI: | http://hdl.handle.net/2445/189351 |
Related resource: | https://doi.org/10.1080/09540121.2022.2067518 |
ISSN: | 0954-0121 |
Appears in Collections: | Articles publicats en revistes (Biologia, Sanitat i Medi Ambient) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
724351.pdf | 1.88 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License